Cold Plasma Market

Global Cold Plasma Market is projected to surge at a robust CAGR of 16% by 2026


Growing prevalence of cold plasma in cancer and infectious disease treatment, growing awareness of cold plasma in the medical, electronics and electrical, textile and food industries, and rising demand for environmentally friendly cold plasma techniques are some of the key factors driving the global cold plasma market.

Cold plasma, the fourth state of matter, is a partly ionized gas composed of ions, electrons, ultraviolet photons, and reactive neutrals such as radicals, excited and ground-state molecules. Plasmas can also be created intentionally by dissociating gas using electricity, microwave radiation, or heat under ambient circumstances. Cold plasma is used in bioengineering, medicine, and therapies due to its low heat capacity.

Cold Plasma Market Driven by Growing Adoption of Cold Atmospheric Plasma (CAP) Therapy in Wound Healing

Cold atmospheric plasma treatment is a novel and cutting-edge method in plasma medicine. It is made up of a variety of reactive species that transmit antibacterial activity and damage human tissues. Because of its non-invasive and environmentally friendly character, this approach has been commended and encouraged for use in a variety of therapeutic regimes such as wound healing, tissue regeneration, and skin infection control. Atmospheric pressure cold plasmas may influence distinct stages of wound healing by activating microorganisms in the first stage and stimulating skin-related cell proliferation and migration in the second.

See also  Navigating the Growth Trajectory: The Global Diagnostic Imaging Market Outlook for 2028

Use of Cold Plasma in Dentistry and Oncology Increase Demand in the Cold Plasma Market

Cold (non-thermal) plasma therapy can be used to prevent or remove bacterial, bacterial biofilm, fungal, and viral infections. Cold plasma’s prospects in dentistry and cancer appear promising due to its antimicrobial characteristics and cell killing properties on cells. Cold plasma has shown encouraging outcomes in tooth whitening, biofilm deactivation in teeth, tool sterilization, and composite repair in dentistry. Cold plasma in oncology has shown promising results in in vivo and in vitro investigations, indicating that it will find a position in the treatment of cancer patients in the future. However, additional research into the mechanism of action is required.

“Growing usage of advanced technologies will drive the market. For instance, the extensive uses of dielectric barrier discharge (DBD) and the non-equilibrium atmospheric pressure plasma jet (N-APPJ) plasma discharge methods have been very effective in various biomedical applications.” — Chief Researcher, Cold Plasma Product Manufacturer, United States

The Asian Cold Plasma Market is Expected to Expand

See also  Global Medical Display Market is Poised to witness a growth rate of CAGR ~5% by 2027

Because of the adoption of technologically advanced cold plasma products in the healthcare industry, rising demand for decontaminated frozen food, and increased manufacturing in the semiconductor, textile, and polymer industries in this region, the APAC cold plasma market is expected to grow rapidly in the coming years. The expansion of the European area market is attributable to increased R&D activity, the availability of numerous FDA-approved medicines, and the presence of some of the region’s main companies.

Competitive Landscape Analysis: Cold Plasma Market

Some of the key players operating in the cold plasma market are Apyx Medical Corporation, Nordson Corporation, P2i, and Relyon Plasma GmbH, among others.

Companies Aggressive Growth Strategies to Increase their Market Share in Cold Plasma Market

Players operating in the global cold plasma market are adopting organic and inorganic growth strategies such as collaborations, acquisitions, and new product launches to garner higher market share. For instance,

  • In October 2021, Plasmacure secured a new series of funding from a consortium with Topfonds Gelderland, NextGen Ventures, European Innovation Council (EIC) Fund, and Credenti B.V. (a group of informal investors) to carry out clinical studies and to sell their product internationally.
  • In October 2021, Reylon Plasma announced the launch of its compact integration solution piezobrush ® PZ3-I in Bondexpo trade fair preview. The compact integration solution is suitable for a wide variety of surface applications.
See also  Global Continuous Renal Replacement Therapy (CRRT) Market is Projected to grow at a CAGR of ~7–9% by 2027

Explore Detailed Insights on Cold Plasma Market @

Leave a Reply

Your email address will not be published. Required fields are marked *